13.11.2020 H&R GmbH & Co. KGaA  DE000A2E4T77

DGAP-News: H&R GmbH & Co. KGaA publishes Quarterly Statement for third quarter of 2020


 

DGAP-News: H&R GmbH & Co. KGaA / Key word(s): 9 Month figures/Quarterly / Interim Statement
H&R GmbH & Co. KGaA publishes Quarterly Statement for third quarter of 2020

13.11.2020 / 11:11
The issuer is solely responsible for the content of this announcement.


Press Release

H&R GmbH & Co. KGaA: Quarterly statement for third quarter of 2020

- Recovery continued in third quarter of 2020

- EBITDA with EUR 14.1 million significantly above previous year

- Earnings projections of up to EUR 45.0 million confirmed

Salzbergen, November 13, 2020. H&R GmbH & Co. KGaA (abbrev.: H&R KGaA; ISIN DE000A2E4T77) has confirmed its preliminary revenue and earnings figures for the third quarter of 2020: Between July and September 2020 the company achieved a consolidated operating income (EBITDA - consolidated income before tax, other financial income and expenses and depreciation/amortization, impairment and appreciation of fixed assets and property, plant and equipment ) of EUR 14.1 million (Q3-2019: EUR 5.1 million.). It not only significantly exceeded the same quarter of the previous year, but also marked the strongest contribution to operating earnings in 2020. EBIT closed at EUR 1.9 million after last year's EUR -6.5 million. Earnings before taxes (EBT) in the third quarter of 2020 were almost balanced at EUR -0.1 Million (Q3-2019: EUR -8.4 million), the company closed the net income attributable to shareholders with EUR -1.2 million (Q3-2019: EUR -6.0 million). Sales revenues in the third quarter of the current financial year fell to EUR 208.1 million (Q3-2019: EUR 274.7 million), in particular due to purchase quantities that increased during the current year but did not reach previous years' figures.

Overview of main key figures:

in million EUR 9 months 2020 9 months 2019 Diff. absolute
Sales Revenues 649.9 824.7 -174.8
ChemPharm REFINING 397.5 513.8 -116.3
ChemPharm SALES 229.5 285.4 -55.9
PLASTICS 29.2 32.9 -3.7
Consolidation -6.4 -7.4 1.0
       
Consolidated Operative Income (EBITDA) 30.7 44.8 -14.1
ChemPharm REFINING 15.7 27.0 -11.3
ChemPharm SALES 17.8 22.5 -4.7
PLASTICS 0.2 -5.4 5.6
Consolidation -3.0 0.7 -3.7
       
EBIT -6.8 11.4 -18.2
EBT -12.8 5.6 -18.4
Net income attributable to shareholders -14.8 4.1 -18.9
Earnings per share (EUR) -0.40 0.11 -0.51
Operative Cashflow 44.6 71.1 -26.5
Free Cashflow 14.4 24.6 -10.2
  Q3-2020 Q3-2019 Diff. absolute
Sales Revenues 208.1 274.7 -66.6
ChemPharm REFINING 120.6 168.4 -47.8
ChemPharm SALES 78.6 97.4 -18.8
PLASTICS 11.0 10.9 0.1
Consolidation -2.1 -2.1 0.0
       
Consolidated operative income (EBITDA) 14.1 5.1 9.0
ChemPharm REFINING 8.7 4.1 4.6
ChemPharm SALES 6.5 7.3 -0.8
PLASTICS 0.4 -5.0 5.4
Consolidation -1.4 -1.3 -0.1
       
EBIT 1.9 -6.5 8.4
EBT -0.1 -8.4 8.3
Net income attributable to shareholders -1.2 -6.0 4.8
Earnings per share (EUR) -0.03 -0.16 0.13
Operative cashflow 5.2 20.0 -14.8
Free cashflow 0.8 3.7 -2.9
  30/9/2020 31/12/2019 Diff. absolute
Balance sheet total 765.7 838.6 -72.9
Equity 338.5 363.4 -24.9
Equity ratio (%) 44.2 43.3 0.9
 

For the full year H&R currently expects an achievable EBITDA of up to EUR 45.0 million.

For further statements on the trends in business performance and earnings, the company refers to the quarterly report for the third statement of 2020, published today, which is available for download at www.hur.com in the "Investor Relations" section.

Contact information:
H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser
Neuenkirchener Strasse 8, 48499 Salzbergen
Phone.: +49 40 43218-321, Fax: +49 40 43218-390
Email: [email protected] ; www.hur.com

H&R GmbH & Co. KGaA:
H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.

Forward-looking statements and forecasts:
This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.



13.11.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: H&R GmbH & Co. KGaA
Neuenkirchener Str. 8
48499 Salzbergen
Germany
Phone: +49 (0)40 43 218 321
Fax: +49 (0)40 43 218 390
E-mail: [email protected]
Internet: www.hur.com
ISIN: DE000A2E4T77
WKN: A2E4T7
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1147870

 
End of News DGAP News Service

1147870  13.11.2020 

fncls.ssp?fn=show_t_gif&application_id=1147870&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 982,91 942,65 1.025,11 1.114,15 1.075,32 873,03 1.150,00
EBITDA1,2 86,00 101,40 97,39 74,70 52,90 55,72 126,50
EBITDA-Marge3 8,75 10,76 9,50 6,70 4,92 6,38 11,00
EBIT1,4 48,89 54,16 54,29 40,17 7,40 -0,35 72,00
EBIT-Marge5 4,97 5,75 5,30 3,61 0,69 -0,04 6,26
Jahresüberschuss1 27,26 39,29 29,50 22,32 0,08 -7,83 40,00
Netto-Marge6 2,77 4,17 2,88 2,00 0,01 -0,90 3,48
Cashflow1,7 56,43 75,45 46,19 23,32 95,86 60,15 95,00
Ergebnis je Aktie8 0,77 1,07 0,88 0,59 -0,04 -0,24 1,05
Dividende8 0,00 0,00 0,40 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Warth & Klein Grant Thornton

INVESTOR-INFORMATIONEN
©boersengefluester.de
H&R
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2E4T7 7,320 Kaufen 272,46
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
8,13 11,97 0,74 31,69
KBV KCV KUV EV/EBITDA
0,76 4,53 0,24 3,58
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,00 0,00 0,00 09.07.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
14.05.2021 13.08.2021 12.11.2021 07.04.2022
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-18,50% -8,07% 33,82% 28,42%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu H&R GmbH & Co. KGaA  ISIN: DE000A2E4T77 können Sie bei DGAP abrufen

Chemie , A2E4T7 , 2HRA , XETR:2HRA